The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
1.92
5 yrs 11 m
0.5%
3,138.46 Crs
0.50% on or before 1M, Nil after 1M
Mid Growth
8.22
SIP 100 & Lumpsum 100
BSE HEALTH CARE - TRI
Chirag Dagli
Investors understand that their principal will be at very high risk